LMR Partners’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
LMR Partners's INMB Position: Q3 2026 in Review
LMR Partners held its INmune Bio (INMB) position steady in Q3 2026 at 16,600 shares worth $32.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.
LMR Partners first reported a position in INMB in Q3 2025 and has held it in 5 quarters since. The position peaked at $34.4K in Q3 2025. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.
- LMR Partners held 16,600 shares of INmune Bio worth $32.4K as of Q3 2026.
- LMR Partners left its INmune Bio share count unchanged in Q3 2026.
- INmune Bio made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1519 holding.
- LMR Partners first reported a position in INmune Bio in Q3 2025 and has held it in 5 quarters since.
- LMR Partners's INmune Bio position peaked at $34.4K in Q3 2025.
- 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.